Mathieu Chevrier

Stock Analyst at Citigroup

(0.43)
# 3,927
Out of 4,820 analysts
2
Total ratings
n/a
Success rate
-5.05%
Average return
Main Sectors:

Stocks Rated by Mathieu Chevrier

ResMed
Mar 5, 2025
Upgrades: Buy
Price Target: n/a
Current: $235.88
Upside: -